Trypsinogen activation in rat pancreatic acinar cells hyperstimulated by caerulein

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1362, Issue 2-3, 1997, Pages 243-251

  Halangk, Walter ^a   Stürzebecher, Jörg ^b   Matthias, Rainer ^a   Schulz, Hans Ulrich ^a   Lippert, Hans ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Benzamidine; Cathepsin B inhibitor; Pancreatic acinar cell; Rhodamine 110 based substrate; Trypsin(ogen)

Indexed keywords

BENZAMIDINE; CATHEPSIN B; CERULETIDE; RHODAMINE 110; SERINE PROTEINASE INHIBITOR; SOYBEAN TRYPSIN INHIBITOR; TRYPSINOGEN;

ACINAR CELL; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME DEGRADATION; FEMALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CAERULEIN; CATHEPSIN B; ENZYME ACTIVATION; FEMALE; PANCREAS; RATS; RATS, WISTAR; TRYPSIN INHIBITORS; TRYPSINOGEN;

ANIMALIA; GLYCINE MAX; TRIXIS;

EID: 0031593171     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4439(97)00082-3     Document Type: Article

References (20)

1. [1] R. Bialek, S. Willemer, R. Arnold, G. Adler, Evidence of intracellular activation of serine proteases in acute caerulein-induced pancreatitis in rats, Scand. J. Gastroenterol. 26 (1991) 190-196.
2. [2] M.L. Steer, A.K. Saluja, Experimental acute pancreatitis: Studies of the early events that lead to cell injury, in: V.L.W. Go, E. P. DiMagno, J.D. Gardner, E. Lebenthal, H.A. Reber, G.A. Scheele (Eds.), The Pancreas: Biology, Pathobiology, and Disease, Raven Press, New York, 1993, pp. 489-500
3. [3] R. Lüthen, C. Niederau, J.H. Grendell, Intrapancreatic zymogen activation and levels of ATP and glutathione during caerulein pancreatitis in rats, Am. J. Physiol. 268 (1995) G592-G604.
4. [4] G. Scheele, G. Adler, H. Kern, Exocytosis occurs at the lateral plasma membrane of the pamcreatic acinar cell during supramaximal secretagogue stimulation, Gastroenterology 92 (1987) 345-353.
5. [5] F.S. Gorelick, G. Adler, H.F. Kern, Cerulein-induced pancreatitis, in: V.L.W. Go, E.P. DiMagno, J.D. Gardner, E. Lebenthal, H.A. Reber, G.A. Scheele (Eds.), The Pancreas: Biology, Pathobiology, and Disease, Raven Press, New York, 1993, pp. 501-526
6. [6] H. Yamaguchi, T. Kimura, K. Kimura, N. Nawata, Activation of proteases in caerulein-induced pancreatitis, Pancreas 4 (1989) 565-571.
7. [7] T. Grady, A. Saluja, A. Kaiser, M. Steer, Edema and intrapancreatic trypsinogen activation precede glutathione depletion during caerulein pancreatitis, Am. J. Physiol. 271 (1996) G20-G26.
8. [8] S.D. Leach, I.M. Modlin, G.A. Scheele, F.S. Gorelick, Intracellular activation of digestive zymogens in rat pancreatic acini. Stimulation by high doses of cholecystokinin, J. Clin. Invest. 87 (1991) 362-366.
9. [9] S.P. Leytus, L.L. Melhado, W.F. Mangel, Rhodamine-based compounds as fluorogenic substrates for serine proteinases, Biochem. J. 209 (1983) 299-307.
10. [10] S.P. Leytus, W.L. Patterson, W.F. Mangel, New class of sensitive and selective fluorogenic substrates for serine proteinases, Biochem. J. 215 (1983) 253-260.
11. [11] G. Rothe, S. Klingel, I. Assfalg-Machleidt, W. Machleidt, C. Zirkelbach, R.B. Banati, W.F. Mangel, G. Valet, Flow cytometric analysis of protease activities in vital cells, Biol. Chem. Hoppe-Seyler 373 (1992) 547-554.
12. [12] J. Stürzebecher, D. Prasa, J. Hauptmann, P. Wikström, H. Vieweg, Synthesis and structure-activity relationships of potent thrombin inhibitors: piperazides of 3-amidinophenylalanine, J. Med. Chem. 40 (1997) 3091-3099.
13. [13] A. Amsterdam, J.D. Jamieson, Structural and functional characterization of isolated pancreatic exocrine cells, Proc. Natl. Acad. Sci. U.S.A. 69 (1972) 3028-3032.
14. [14] J.A. Williams, M. Korc, R.L. Dormer, Action of secretagogues on a new preparation of functionally intact, isolated pancreatic acini, Am. J. Physiol. 235 (1978) E517-E524.
15. [15] A. Saluja, H. Sadamitsu, M. Saluja, R.E. Powers, J. Meldolesi, M.L. Steer, Subcellular redistribution of lysosomal enzymes during caerulein-induced pancreatitis, Am. J. Physiol. 253 (1987) G508-G516.
16. [16] R.T. Jensen, G.F. Lemp, J.D. Gardner, Interaction of cholecystokinin with specific membrane receptors on pancreatic acinar cells, Proc. Natl. Acad. Sci. U.S.A. 77 (1980) 2079-2083.
17. [17] F.S. Gorelick, L.M. Matovcik, Lysosomal enzymes and pancreatitis, Gastroenterology 109 (1995) 620-625.
18. [18] C. Figarella, B. Miszczuk-Jamska, A.J. Barrett, Possible lysosomal activation of pancreatic zymogens, Biol. Chem. Hoppe.Seyler 369 (1988) 293-298.
19. [19] D.C. Whitcomb, M.C. Gorry, R.A. Preston, W. Furey, M.S. Sossenheimer, C.D. Ulrich, S.P. Martin, L.K. Gates Jr, S.T. Amann, P.P. Toskes, R. Liddle, K. McGrath, G. Uomo, J.C. Post, G.D. Ehrlich, Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene, Nat. Genet. 14 (1996) 141-145.
20. [20] T. Towatari, T. Nikawa, M. Murata, C. Yokoo, M. Tamai, K. Kanada, N. Katunuma, Novel epoxysuccinyl peptides. A selective inhibitor of cathepsin B, in vivo, FEBS Lett. 280 (1991) 311-315.